CML-N, however, is characterized by an uncommon BCR-ABL translocation which results in the transcription of an e19/a2 type BCR-ABL messenger RNA yielding a 230-kD BCR-ABL protein (p230)12,36. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.